North Staffordshire Joint Formulary
North Staffordshire Clinical Commissioning Group
Stoke-on-Trent Clinical Commissioning Group

 
back
11 Eye
11-08-02 Subfoveal choroidal neovascularisation

Aflibercept Eylea®
Formulary

Eylea 2mg/50microlitres solution for injection vials

Restriction: In line with NICE Guidance only

Link  NICE TA294: Aflibercept solution for injection for treating wet age‑related macular degeneration
Link  NICE TA305: Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion
Link  NICE TA346: Aflibercept for treating diabetic macular oedema
Link  NICE TA409: Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion
Link  NICE TA486: Aflibercept for treating choroidal neovascularisation
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Ranibizumab Lucentis®
Formulary

Lucentis 1.65mg/0.165ml solution for injection pre-filled syringes
Lucentis 2.3mg/0.23ml solution for injection vials

Restriction: In line with NICE Guidance only

Link  NICE TA155: Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Link  NICE TA274: Ranibizumab for treating diabetic macular oedema
Link  NICE TA283: Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion
Link  NICE TA298: Ranibizumab for treating choroidal neovascularisation associated with pathological myopia
 

Red View adult BNF  View SPC online  View childrens BNF  HCD
Verteporfin Visudyne®
Formulary

15mg powder for solution for infusion vials

Restriction: In line with NICE Guidance only

 

Link  NICE NG82: Age-related macular degeneration
 

Red View adult BNF  View SPC online  View childrens BNF  HCD